TrialBritish journal of haematology2020

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.

Catherine Thieblemont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.